Home On Pins and Needles

On Pins and Needles

Hello! I’m Lydia Kim, the digital content editor for American Nurse. Part of my role is expanding the types of content and the diversity of voices included on our journal’s digital platforms. I’ve also been tasked with creating original content that’s meaningful to our readers. As a trained linguist, I’m passionate about language, and I’m especially interested in how language and healthcare intersect. In addition to sharing information about the latest healthcare news or advocacy events that impact your daily nursing practice, I hope On Pins and Needles can be a platform for sharing my passion for the language and offer you a new perspective.

If you have any suggestions for my blog, please submit a comment, or e-mail me at LKim@healthcommedia.com. I look forward to hearing from you!

Blog Posts

Top apps for nurses in 2020

With 2020 coming to an end, the American Nurse Journal team would like to highlight some of the best apps for nurses and nursing students from the past year. We recently highlighted the best...

Potential vaccine for Alzheimer’s Disease progession

In an effort to honor National Alzheimer’s Disease Month, we would like to highlight a new study which may offer hope to those within the Alzheimer’s Disease (AD) community; a new vaccine is being...

Study reveals connection between use of proton pump inhibitors and risk of type 2...

A study published in BMJ Gut examined “the association between the regular use of proton pump inhibitors (PPI) and the risk of type 2 diabetes.” The study followed over 200,000 participants who did not have...

Ultra-processed food may affect health while aging

A recent study published in The American Journal of Clinical Nutrition examines the effects of consuming ultra-processed foods (UPF) and telomere length, which is a “marker of biological age.” The objectives of the research was...

New research on the connection between genetics and wound healing

A new study published in Plos Pathogens examines the connection between wound microbiomes and wound healing. This study was described as “being the first to identify patient genetic determinants for wound microbiomes and healing.” A...

Meditation-based therapy may reduce occurrence of sleep paralysis

A new study published in Frontiers in Neurology explores a new therapeutic technique to reduce the occurrence of sleep paralysis (SP) in patients with narcolepsy. SP involves a feeling of paralysis a person may...

New study focuses on wound healing mechanisms

A new study recently published in Nature Communications focuses on the “biomechanical properties of skin wounds.” The researchers examined the body’s “repair program” and how it works to repair an injured area. Ultimately, the researchers...

Top mental health apps for nurses

Whether you personally struggle with mental health concerns, or your patients are, your phone can be a valuable tool in the efforts to work through anxiety and stress. To recognize Mental Health Awareness Month...
cannabis

New research on possible adverse events to cannabis

A new study recently published in the Journal of Cannabis Research examines the potential “acute adverse reactions” associated with cannabis use. The study examined self-reported adverse reactions from 999 cannabis users and revealed that the...
brain health

Study examines connection between brain health and sleep-disordered breathing

A new study recently published in JAMA Neurology examines if there is a potential link between brain health and “sleep-disordered breathing (SLB).” The study examined over 100 “community-dwelling” adults who had cognitive impairments and if...

Highlighting the CNO’s role: An interview with Linda Stoverock

The American Nurse team is delighted to have had an opportunity to speak with Linda Stoverock, a nurse who is retiring after a 43-year long career in the nursing field, 20 of which has been as...

New treatment for multiple myeloma

The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of  adult patients with multiple myeloma. Isatuximab-irfc was previously designated its orphan drug status by the FDA. Isatuximab-irfc was approved...

First genetic test for Fragile X Syndrome

The U.S. Food and Drug Administration (FDA) recently approved marketing for the very first genetic test to help diagnose Fragile X Syndrome (FXS). FXS is a genetic disorder which affects approximately 1 in every 4,000...